NCT06187142

Brief Summary

The study aims to facilitate mobile phone-based cessation support for chronic patients using a sequential multiple assignment randomized trial (SMART) , and combines different effective treatments to enhance engagement and determine the most effective adaptive interventions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 2, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

August 19, 2024

Status Verified

December 1, 2023

Enrollment Period

7 months

First QC Date

December 16, 2023

Last Update Submit

August 16, 2024

Conditions

Keywords

Smoking cessationChronic patientsSMART design

Outcome Measures

Primary Outcomes (1)

  • Participation rate of eligible smokers (Feasibility)

    The percentage of eligible smokers who agree to participate in the intervention

    Baseline

Secondary Outcomes (8)

  • Validated and self-reported abstinence of PCS vs. GCS

    3- and 6-month follow-up

  • Validated and self-reported abstinence of PCS-3 vs. GCS-2

    3- and 6-month follow-up

  • Validated and self-reported abstinence of PCS-3 vs. PCS-2

    3- and 6-month follow-up

  • Validated and self-reported abstinence of GCS-3 vs. GCS-2

    3- and 6-month follow-up

  • Validated and self-reported abstinence of PCS-1+2 vs. GCS-1+2

    3- and 6-month follow-up

  • +3 more secondary outcomes

Study Arms (2)

Intervention Group (Group PCS, subgroup PCS-1+PCS-2+PCS-3)

EXPERIMENTAL

Personalized Chat Support (PCS) + Multi-component Optional Support (MOS) + 5A's / 5R's advice + health warning leaflet +Self-help booklet

Behavioral: Initial phase: Personalized Chat Support (PCS)Behavioral: Second phase: Multi-component Optional Support (MOS)Behavioral: 5A's / 5R's adviceBehavioral: health warning leafletBehavioral: Self-help booklet

Control Group (Group GCS, subgroup GCS-1+GCS-2+GCS-3)

EXPERIMENTAL

Group Chat Support (GCS) + Personalized Chat Support (PCS) + 5A's / 5R's advice + health warning leaflet +Self-help booklet

Behavioral: Initial phase: Group Chat Support (GCS)Behavioral: Second phase: Personalized Chat Support (PCS)Behavioral: 5A's / 5R's adviceBehavioral: health warning leafletBehavioral: Self-help booklet

Interventions

Participants will receive three months of personalized chat support through WeChat. A total of 24 pre-set messages will be sent with the schedule of 3 times a week for 2 weeks, twice a week for the next 8 weeks and once a week for the last 2 weeks. These messages cover generic information about the benefits of quitting, methods to avoid/ manage craving or withdrawal symptoms, and hazards of smoking for chronic diseases experienced by different participants. Counsellors will respond to the participants' messages instantly. At the end of the initial phase (1-month), complete responders (quitters) will continue to receive PCS (subgroup PCS-1). Incomplete responders (smokers) will be randomly assigned to continue PCS (subgroup PCS-2) or receive PCS and MOS (subgroup PCS-3).

Intervention Group (Group PCS, subgroup PCS-1+PCS-2+PCS-3)

For incomplete responders (subgroup PCS-3) randomized to MOS, the available intervention options include phone counseling, family/peer support group and financial incentive for nicotine replacement therapy. Participants will be guided by cessation counsellors at 1-month follow-up to choose any combination of MOS based on their prefer choice or combination of MOS. If MOS participants cannot be followed up at 1-month, they will continue PCS by default.

Intervention Group (Group PCS, subgroup PCS-1+PCS-2+PCS-3)

Participant will receive three months of group chat support through WeChat. In this group, participants can send 'No Smoking' and the smart quit-smoking assistant will record it. A smoking cessation clinic doctor in the group will respond to participants' questions about smoking cessation. At the end of the initial phase (1-month), complete responders (quitters) will continue to receive GCS (subgroup GCS-1). Incomplete responders (smokers) will be randomly assigned to continue GCS (subgroup GCS-2) or receive GCS and PCS (subgroup GCS-3).

Control Group (Group GCS, subgroup GCS-1+GCS-2+GCS-3)

For incomplete responders (subgroup GCS-3) randomized to PCS, participants will receive the same intervention as Group PCS delivered at the initial stage. Participants will receive two months of personalized messages through WeChat. Please refer to Intervention Group 'Initial phase: Personalized Chat Support (PCS) for details.

Control Group (Group GCS, subgroup GCS-1+GCS-2+GCS-3)

5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.

Control Group (Group GCS, subgroup GCS-1+GCS-2+GCS-3)Intervention Group (Group PCS, subgroup PCS-1+PCS-2+PCS-3)

The contents of the leaflet include the absolute risk of smoking, diseases caused by active and second-hand smoking, horrible pictorial warnings of the health consequences of active and second-hand smoking, and the benefits of quitting.

Control Group (Group GCS, subgroup GCS-1+GCS-2+GCS-3)Intervention Group (Group PCS, subgroup PCS-1+PCS-2+PCS-3)

The contents include information about the benefits of quitting, methods to quit, how to handle withdrawal symptoms, misperceptions of quitting, etc.

Control Group (Group GCS, subgroup GCS-1+GCS-2+GCS-3)Intervention Group (Group PCS, subgroup PCS-1+PCS-2+PCS-3)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 or above, reside in Zhuhai for next 6 months;
  • smoke at least 1 cigarette or use e-cigarettes daily;
  • having a smartphone and a WeChat account, being able to use WeChat skillfully;
  • having a diagnosis of at least one chronic disease related to smoking;
  • intent to quit / reduce smoking.

You may not qualify if:

  • smokers who have communication barrier (either physically or cognitively)
  • having participation in other smoking cessation programmes or services

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Normal University

Zhuhai, Guangdong, 519087, China

Location

Related Publications (1)

  • Weng X, Song C, Liu K, Zhao S, Yang H, Wang MP. Mobile Phone-Based Smoking-Cessation Intervention in Patients With Chronic Diseases in China: A Sequential Multiple Assignment Randomized Trial. Nicotine Tob Res. 2025 Feb 24;27(3):502-510. doi: 10.1093/ntr/ntae230.

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2023

First Posted

January 2, 2024

Study Start

January 1, 2024

Primary Completion

July 15, 2024

Study Completion

December 15, 2024

Last Updated

August 19, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations